comparemela.com
Home
Live Updates
Why Eli Lillys earnings are no sure thing for traders despite obesity drug momentum : comparemela.com
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
The Food and Drug Administration said supplies of Zepbound and Mounjaro are expected to be limited through the second quarter, for all but one dosage.
Related Keywords
Mounjaro Zepbound ,
Eli Lilly ,
James Shin ,
Jo Walton ,
David Risinger ,
Fargo Mohit Bansal ,
Deutsche Bank Shin ,
Deutsche Bank ,
Drug Administration ,
Wall Street ,
Health Care Industry ,
Earnings ,
Eli Lilly And Co ,
Investment Strategy ,
Business News ,
comparemela.com © 2020. All Rights Reserved.